Mariner
VNDA icon

Mariner’s Vanda Pharmaceuticals VNDA Stock Holding History

Mariner’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
173,480
+93,626
+117% +$612K ﹤0.01% 1904
2026
Q1 		$552K Buy
79,854
+63,025
+375% +$486K ﹤0.01% 2420
2025
Q4 		$146K Sell
16,829
-566
-3% -$3.12K ﹤0.01% 3251
2025
Q3 		$86.8K Buy
+17,395
New +$80.5K ﹤0.01% 3385

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mariner's VNDA Position: Q2 2026 in Review

Mariner increased its Vanda Pharmaceuticals (VNDA) stake by 117% in Q2 2026, buying an estimated $612K and bringing the position to 173,480 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Mariner first reported a position in VNDA in Q3 2025 and has held it in 4 quarters since. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Mariner held 173,480 shares of Vanda Pharmaceuticals worth $1.06M as of Q2 2026.
  • Mariner bought 93,626 Vanda Pharmaceuticals shares in Q2 2026, an estimated $612K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1904 holding.
  • Mariner first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.